AMPIVIEW
Live / Registered — Registered (as of 03 Oct 2023)
What this means for you
Registered since 03 Oct 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 03 Oct 2029: the §8 declaration of use).
Record
- Serial number
- 97013293
- Registration number
- 7183829
- Mark type
- Word mark
- Filed
- 06 Sept 2021
- Published for opposition
- 07 Mar 2023
- Registered
- 03 Oct 2023
- Next maintenance filing
- §8 declaration of use, due by 03 Oct 2029 (grace period to 03 Apr 2030)
- Attorney of record
- Joel E. Tragesser
Goods and services
- Class 001 — Chemicals: Reagents for scientific or medical research use, namely, nucleic acid type reagents for in vitro laboratory use
Owner
- Enzo Life Sciences, Inc., Farmingdale, NY, US
- Enzo Life Sciences, Inc., Farmingdale, NY, US
- Enzo Life Sciences, Inc., Farmingdale, NY, US
Prosecution history
- 03 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 31 Aug 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Aug 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Aug 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Jul 2023 — USE AMENDMENT FILED
- 07 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Jul 2023 — TEAS STATEMENT OF USE RECEIVED
- 02 May 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Mar 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Mar 2023 — PUBLISHED FOR OPPOSITION
- 15 Feb 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Feb 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Dec 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Dec 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE